Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancer

Semin Oncol. 1994 Dec;21(6 Suppl 16):44-50.

Authors

P H Willemse¹, H Boonstra, E G de Vries

Affiliation

¹ Department of Medical Oncology, University Hospital Groningen, The Netherlands.

PMID: 7528450

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bone Marrow Diseases / chemically induced
Bone Marrow Diseases / drug therapy
Bone Marrow Transplantation
Chemotherapy, Adjuvant
Clinical Trials as Topic
Colony-Stimulating Factors / therapeutic use*
Dose-Response Relationship, Drug
Female
Granulocyte Colony-Stimulating Factor / therapeutic use
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
Humans
Interleukin-3 / therapeutic use
Ovarian Neoplasms / drug therapy*
Ovarian Neoplasms / therapy

Substances

Colony-Stimulating Factors
Interleukin-3
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor